CMPS vs CNTN

COMPASS Pathways Plc - American vs Canton Strategic Holdings, Inc. — Valuation Comparison 2026

CMPS

Pharmaceutical Preparations
COMPASS Pathways Plc - American
Quality
1.9
out of 10
Value Trap
12
SAFE
Price
$13.06
Last close
Models
9/13
Active
VS

CNTN

Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
Quality
3.5
out of 10
Value Trap
24
SAFE
Price
$3.10
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType CMPS Fair ValueCMPS Upside CNTN Fair ValueCNTN Upside
Bayesian DCF Intrinsic $2.95 -77.4% $1.19 -61.6%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $5.77 -55.8% $2.82 -9.0%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $14.06 +24.7%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CMPS vs CNTN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CMPS vs CNTN — Which Stock Is More Undervalued?

CNTN scores higher with a 3.5/10 quality rating vs CMPS's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing COMPASS Pathways Plc - American (CMPS) and Canton Strategic Holdings, Inc. (CNTN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CMPS currently trades at $13.06 with a QOC of 1.9/10, while CNTN trades at $3.10 with a QOC of 3.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).